Paediatric Hepatology Associates Limited - Abbreviated accounts 16.1

REGISTERED NUMBER: 07181977 (England and Wales)

Abbreviated Accounts

for the Year Ended 31 March 2016

for

PAEDIATRIC HEPATOLOGY ASSOCIATES LIMITED

Page

Company Information

1

Abbreviated Balance Sheet

2

Notes to the Abbreviated Accounts

4

DIRECTORS:

Dr A J Baker

Professor A Dhawan

Dr N Hadzic

SECRETARY:

Dr A J Baker

REGISTERED OFFICE:

1 Brook Court

Blakeney Road

Beckenham

Kent

BR3 1HG

REGISTERED NUMBER:

07181977 (England and Wales)

ACCOUNTANTS:

Maths Partnership

1 Brook Court

Blakeney Road

Beckenham

Kent

BR3 1HG

FIXED ASSETS

Intangible assets

2

91,751

114,688

CURRENT ASSETS

Debtors

76,876

101,933

Cash at bank and in hand

68,722

43,398

145,598

145,331

CREDITORS

Amounts falling due within one year

127,746

136,029

NET CURRENT ASSETS

17,852

9,302

TOTAL ASSETS LESS CURRENT
LIABILITIES

109,603

123,990

CAPITAL AND RESERVES

Called up share capital

3

300

Profit and loss account

109,303

123,690

SHAREHOLDERS' FUNDS

109,603

123,990

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2016.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2016 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395
and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as
applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the Board of Directors on 19 August 2016 and were signed on its behalf by:

Professor A Dhawan - Director

Dr N Hadzic - Director

1.	ACCOUNTING POLICIES

Accounting convention

The financial statements have been prepared under the historical cost convention and in accordance with the Financial

Reporting Standard for Smaller Entities (effective January 2015).

Turnover

Turnover represents net invoiced sales of goods, excluding value added tax.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2010, is being amortised evenly over its estimated useful life of ten years.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date

where transactions or events have occurred at that date that will result in an obligation to pay more, or a right to pay less or

to receive more tax, with the following exception.

Deferred tax assets are recognised only to the extent that the directors consider that it is more likely than not that there will

be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted.

Deferred tax is measured on an undiscounted basis at the tax rates that are expected to apply in the period in which timing

differences reverse, based on tax rates and laws enacted or substantively enacted at the balance sheet date.

2.	INTANGIBLE FIXED ASSETS

Total

£

COST

At 1 April 2015

and 31 March 2016

229,377

AMORTISATION

At 1 April 2015

114,689

Amortisation for year

22,937

At 31 March 2016

137,626

NET BOOK VALUE

At 31 March 2016

91,751

At 31 March 2015

114,688

3.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.3.16

31.3.15

value:

£

300

Ordinary 'A'

1

300

4.	RELATED PARTY DISCLOSURES

During the year, total dividends of £35,000 were paid to the directors .